Market Research Logo

Colby Pharmaceutical Company - Product Pipeline Review - 2015

Colby Pharmaceutical Company - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Colby Pharmaceutical Company - Product Pipeline Review - 2015’, provides an overview of the Colby Pharmaceutical Company’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Colby Pharmaceutical Company’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Colby Pharmaceutical Company including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Colby Pharmaceutical Company’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Colby Pharmaceutical Company’s pipeline products
Reasons to buy
  • Evaluate Colby Pharmaceutical Company’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Colby Pharmaceutical Company in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Colby Pharmaceutical Company’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Colby Pharmaceutical Company and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Colby Pharmaceutical Company
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Colby Pharmaceutical Company and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues


Colby Pharmaceutical Company Snapshot
Colby Pharmaceutical Company Overview
Key Information
Key Facts
Colby Pharmaceutical Company - Research and Development Overview
Key Therapeutic Areas
Colby Pharmaceutical Company - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Colby Pharmaceutical Company - Pipeline Products Glance
Colby Pharmaceutical Company - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Colby Pharmaceutical Company - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Colby Pharmaceutical Company - Unknown Stage Pipeline Products
Unknown Products/Combination Treatment Modalities
Colby Pharmaceutical Company - Drug Profiles
CPC-551
Product Description
Mechanism of Action
R&D Progress
JVRS-100
Product Description
Mechanism of Action
R&D Progress
JVRSOD
Product Description
Mechanism of Action
R&D Progress
Vaccine for Prostate Cancer
Product Description
Mechanism of Action
R&D Progress
CPC-123
Product Description
Mechanism of Action
R&D Progress
Colby Pharmaceutical Company - Pipeline Analysis
Colby Pharmaceutical Company - Pipeline Products by Target
Colby Pharmaceutical Company - Pipeline Products by Route of Administration
Colby Pharmaceutical Company - Pipeline Products by Molecule Type
Colby Pharmaceutical Company - Pipeline Products by Mechanism of Action
Colby Pharmaceutical Company - Recent Pipeline Updates
Colby Pharmaceutical Company - Dormant Projects
Colby Pharmaceutical Company - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Colby Pharmaceutical Company, Key Information
Colby Pharmaceutical Company, Key Facts
Colby Pharmaceutical Company - Pipeline by Indication, 2015
Colby Pharmaceutical Company - Pipeline by Stage of Development, 2015
Colby Pharmaceutical Company - Monotherapy Products in Pipeline, 2015
Colby Pharmaceutical Company - Phase II, 2015
Colby Pharmaceutical Company - Phase I, 2015
Colby Pharmaceutical Company - Preclinical, 2015
Colby Pharmaceutical Company - Unknown, 2015
Colby Pharmaceutical Company - Pipeline by Target, 2015
Colby Pharmaceutical Company - Pipeline by Route of Administration, 2015
Colby Pharmaceutical Company - Pipeline by Molecule Type, 2015
Colby Pharmaceutical Company - Pipeline Products by Mechanism of Action, 2015
Colby Pharmaceutical Company - Recent Pipeline Updates, 2015
Colby Pharmaceutical Company - Dormant Developmental Projects,2015
Colby Pharmaceutical Company, Subsidiaries
List of Figures
Colby Pharmaceutical Company - Pipeline by Top 10 Indication, 2015
Colby Pharmaceutical Company - Pipeline by Stage of Development, 2015
Colby Pharmaceutical Company - Monotherapy Products in Pipeline, 2015
Colby Pharmaceutical Company - Pipeline by Top 10 Target, 2015
Colby Pharmaceutical Company - Pipeline by Top 10 Route of Administration, 2015
Colby Pharmaceutical Company - Pipeline by Top 10 Molecule Type, 2015
Colby Pharmaceutical Company - Pipeline Products by Top 10 Mechanism of Action, 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report